Lead storyLead story · #macro
Morning Read: Nikkei jumps as ABCL trial results approach
Japanese stocks led a firmer Asian session while U.S. equity futures edged higher into a light Monday data calendar. AbCellera is due to release Phase 2 ABCL635 results before the U.S. open.






